Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fondazione Telethon

www.telethon.it

Latest From Fondazione Telethon

Tech Transfer Roundup: OncoSec Will Investigate CAR-T In Breast Cancer With Dana-Farber

Building on research by Dana-Farber professor Wayne Marasco, the partners are backing a bispecific approach to CAR-Ts in solid tumors. Seelos licenses a Parkinson’s gene therapy candidate from Duke.

Deals Business Strategies

Commercial Considerations For Cell And Gene Therapies: Viewpoints From The 2016 ARM Meeting

There are still many lessons to be learned in commercializing cell and gene therapies. Experts in the industry discussed challenges and best practices at the Alliance for Regenerative Medicine's annual meeting in October.

BioPharmaceutical Commercial

GSK Is First Big Pharma To Seek Gene Therapy Approval, Plans More

Britain’s biggest drug maker is seeking regulatory approval in Europe to use gene transfer technology in children born with ADA-SCID and has further programs using the approach in two other rare diseases - metachromatic leukodystrophy and Wiskott-Aldrich syndrome - with both currently in clinical trials.

BioPharmaceutical Italy

Deal Watch: Valeant’s Financial/Commercial Strength Offers A New Chance For Provenge

AstraZeneca buys out respiratory franchise from Actavis, which it had gained a year prior with its purchase of Forest. Mylan announced two deals Feb. 2, collaborating in COPD with Theravance and buying women’s health products from India’s Famy Care.

BioPharmaceutical Deals
See All
UsernamePublicRestriction

Register